A comparison was firstly done of the oxygen flux through the Bausch and Lomb Plano T lens, the Bausch & Lomb U3 lens, and the Duragel 75 lens with a sensor on the normal eye. The results showed that the Bausch and Lomb Plano T lens was the best for use with the sensor probe. The sensor was then used to obtain a comparison with the normal oxygen flux through a therapeutic lens on keratoplastic e...

purpose: to determine the indications for penetrating keratoplasty (pk) in iran over an 11-year period. methods: all eye bank records of patients who underwent pk from 1994 to 2004 at ophthalmologic centers throughout iran were reviewed. results: during this 11-year period, a total of 19,668 cases were operated. the most common indication for penetrating keratoplasty was keratoconus (34.5%), fo...

Corneal collagen cross-linking with riboflavin and UVA light is a new therapeutic method for increase the biomechanical stability of the cornea through induction of new additional links between collagen fibers. The aim of this paper is to show the mechanism of action of this therapeutically method in different corneal diseases, for which this method can be applied: corneal ectasia, bullous kera...

PURPOSE To determine the leading indication for penetrating keratoplasty. MATERIAL AND METHOD The authors retrospectively performed a chart review of the hospital records of all patients who underwent penetrating keratoplasty at Maharaj Nakorn Chiang Mai Hospital between January 1996 and December 1999. RESULTS A total of 45 corneal transplants were performed. The leading indications for pen...

PURPOSE The surgical treatment of band keratopathy usually consists of abrasion of the corneal epithelium followed by removal of the subepithelial calcium deposits by means of an ethylenediamine-tetraacetic acid (EDTA) solution. In order to reduce the discomfort and pain that occur after corneal abrasion, the authors developed a modified technique that avoids the abrasion of the epithelium. M...

We report a case of vortex keratopathy in a patient treated with vandetanib for non-small cell lung cancer (NSCLC). A 44-year-old female who underwent two cycles of chemotherapy for NSCLC complained of visual blurring in both eyes after the initiation of vandetanib, an anti-epidermal growth factor receptor (EGFR) and anti-vascular endothelial growth factor receptor 2 protein tyrosine kinase inh...